The dimer interfaces of protease and extra-protease domains influence the activation of protease and the specificity of GagPol cleavage

Journal of Virology

Volumn 77, Issue 1, 2003, Pages 366-374

  Pettit, Steven C ^a   Gulnik, Sergei ^b   Everitt, Lori ^a   Kaplan, Andrew H ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Tibotec Inc   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; GAG PROTEIN; NUCLEOCAPSID PROTEIN; POL PROTEIN; PROTEINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; DIMERIZATION; ENZYME ACTIVATION; ENZYME SPECIFICITY; GENE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ASSEMBLY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; DIMERIZATION; ENZYME ACTIVATION; FUSION PROTEINS, GAG-POL; HIV PROTEASE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN PRECURSORS; SUBSTRATE SPECIFICITY;

EID: 0037213627     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.1.366-374.2003     Document Type: Article

References (55)

1. Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1. J. Virol. 70:7228-7232.
2. Amann, E., J. Brosius, and M. Ptashne. 1983. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. Gene 25:167-178.
3. Baum, E. Z., G. A. Behernitz, and Y. Gluzman. 1990. β-galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immonodeficiency virus protease. Proc. Natl. Acad. Sci. USA 87:10023-10027.
4. Bebenek, K., and T. A. Kunkei. 1989. The use of native T7 DNA polymerase for site-directed mutagenesis. Nucleic Acids Res. 17:5408.
5. Bennett, R. P., T. D. Nelle, and J. W. Wills. 1993. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J. Virol. 67:6487-6498.
6. Billich, S., M. T. Knoop, J. Hansen, P. Strop, J. Sedlacek R. Mertz, and K. Moelling. 1988. Synthetic peptides as substrates and inhibitors of human immune deficiency virusprotease. J. Biol. Chem. 263:17905-17908.
7. Bowzard, J. B., R. P. Bennett, N. K. Krishna, S. M. Ernst, A. Rein, and J. W. Wills. 1998. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue. J. Virol. 72:9034-9044.
8. Carter, C., and G. Zybarth. 1994. Processing of retroviral Gag polyproteins: An in vitro approach. Methods Enzymol. 241:227-253.
9. Chen, N., A. Morag, N. Almog, I. Blumenzweig, O. Dreazin, and M. Kotler. 2001. Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1. J. Gen. Virol. 82:581-590.
10. Co, E., G. Koelsch, Y. Lin, E. Ido, J. A. Hartsuck, and J. Tang. 1994. Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1. Biochemistry 33:1248-1254.
11. 2 symmetric inhibitor complexed to HIV-1 protease. Science 249:527-533.
12. Erickson-Viitanen, S., J. Manfredi, P. Viitanen, D. E. Tribe, R. Tritch, C. A. Hutchison III, D. D. Loeb, and R. Swanstrom. 1989. Cleavage of HIV-1 gag polyprotein synthesized in vitro: Sequential cleavage by the viral protease. AIDS Res. Hum. Retrovit. 5:577-591.
13. Franke, E. K., H. E. Yuan, K. L. Bossolt, S. P. Goff, and J. Luban. 1994. Specificity and sequence requirements for interactions between various retroviral Gag proteins. J. Virol. 68:5300-5305.
14. Gamble, T. R., S. Yoo, F. F. Vajdos, U. K. von Schwedler, D. K. Worthylake, H. Wang, J. P. McCutcheon, W. I. Sundquist, and C. P. Hill. 1997. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278:849-853.
15. Gatlin, J., S. J. Arrigo, and M. G. Schmidt. 1998. HIV-1 protease regulation: The role of the major homology region and adjacent C-terminal capsid sequences. J. Biomed. Sci. 5:305-308.
16. Gorelick, R. J., and L. E. Henderson. 1994. Part III: Analyses, p. 2-5. In G. Myers, B. Korber, S. Wain-Hobson, K. T. Jeans, L. Henderson, and G, Pavlakis (ed.), Human retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos, N.Mex.
17. Gulnik, S. V., L. I. Suvorov, B. Liu, B. Yu, B. Anderson, H. Mitsuya, and J. W. Erickson. 1995. Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure. Biochemistry 34:9282-9287.
18. Henderson, L. E., R. C. Sowder, T. D. Copeland, S. Oroszlan, and R. E. Benveniste. 1990. Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. J. Med. Primatol. 19:411-419.
19. Jacks, T., M. D. Power, F. R. Maslarz, P. A. Luciw, P. J. Barr, and H. E. Varmus. 1988. Characterization of ribosomal frame-shifting in HIV-1 gag/pol expression. Nature 331:280-283.
20. Kaplan, A. H., J. A. Zack, M. Knigge, D. A. Paul, D. J. Kempf, D. W. Norbeck, and R. Swanstrom. 1993. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67:4050-4055.
21. Katz, R. A., and A. M. Skalka. 1994. The retroviral enzymes. Annu. Rev. Biochem. 63:133-173.
22. Krausslich, H. G. 1991. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. USA 88:3213-3217.
23. Kräusslich, H.-G. 1992. Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. J. Virol. 66:567-572.
24. Kräusslich, H.G., M. Fäcke, A.-M. Heuser, J. Konvalinka, and H. Zentgraf. 1995. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69:3407-3419.
25. Kräusslich, H.-G., H. Schneider, G. Zybarth, C. A. Carter, and E. Wimmer. 1988. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J. Virol. 62:4393-4397.
26. Kunkel, T. A., K. Bebenek, and J. McClary. 1991. Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol. 204:125-139.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 277:680-685.
28. Leis, J., D. Baltimore, J. M. Bishop, J. Coffin, E. Fleissner, S. P. Goff, S. Oroszlan, H. Robinson, A. M. Skalka, H. M. Temin, et al. 1988. Standardized and simplified nomenclature for proteins common to all retroviruses. J. Virol. 62:1808-1809.
29. Lindhofer, H., K. von der Helm, and H. Nitschko. 1995. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes. Virology 214:624-627.
30. Loeb, D. D., R. Swanstrom, L. Everitt, M. Manchester, S. E. Stamper, and C. A. Hutchison III. 1989. Complete mutagenesis of the HIV-1 protease. Nature 340:397-400.
31. Louis, J. M., G. M. Clore, and A. M. Gronenborn. 1999. Autoprocesing of HIV-1 protease is tightly coupled to protein folding. Nat. Struct. Biol. 6:868-875.
32. Louis, J. M., F. Dyda, N. T. Nashed, A. R. Kimmel, and D. R. Davies. 1998. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease. Biochemistry 37:2105-2110.
33. Louis, J. M., N. T. Nashed, K. D. Parris, A. R. Kimmel, and D. M. Jerina. 1994. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein. Proc. Natl. Acad. Sci. USA 91:7970-7974.
34. Mervis, R. J., N. Ahmad, E. P. Lillehoj, M. G. Raum, F. H. R. Salazar, H. W. Chan, and S. Venkatesan. 1988. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62:3993-4002.
35. Navia, M. A., P. M. Fitzgerald, B. M. McKeever, C. T. Leu, J. C. Heimbach, W. K. Herher, I. S. Sigal, P. L. Darke, and J. P. Springer. 1989. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1. Nature 337:615-620.
36. Oroszlan, S., and R. B. Luftig, 1990. Retroviral proteinases. Curr. Top. Microbiol. Immunol. 157:153-185.
37. Partin, K., G. Zybarth, L. Ehrlich, M. DeCrombrugghe, E. Wimmer, and C. Carter, 1991. Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 88:4776-4780.
38. Pettit, S. C., M. D. Moody, R. S. Wehbie, A. H. Kaplan, P. V. Nantermet, C. A. Klein, and R. Swanstrom. 1994. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68:8017-8027.
39. Pettit, S. C., J. Simsic, D. D. Loeb, L. Everitt, C. A. Hutchison III, and R. Swanstrom. 1991. Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J. Biol. Chem. 266:14539-14547.
40. Phylip, L. H., J. T, Griffiths, J. S. Mills, M. C. Graves, B. M. Dunn, and J. Kay. 1995. Activities of precursor and tethered dimer forms of H1V proteinase. Adv. Exp. Med. Biol. 362:467-472.
41. Quillent, C., A. M. Borman, S. Paulous, C. Dauguet, and F. Clavel. 1996. Extensive regions of po1 are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology 219:29-36.
42. Ratner, L., A. Fisher, L. L. Jagodzinski, H. Mitsuya, R.-S. Liou, R. C. Gallo, and F. Wong-Staal 1987. Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res. Hum. Retrovir. 3:57-69.
43. Reil, H., H. Kollmus, U. H. Weidle, and H. Hauser. 1993. A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells. J. Virol. 67:5579-5584.
44. Shehu-Xhilaga, M., H. G. Kraeusslich, S. Pettit, R. Swanstrom, J. Y. Lee, J. A. Marshall, S. M. Crowe, and J. Mak. 2001. Proteolytic processing of the P2 [sic]/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J. Virol. 75:9156-9164.
45. * protein is essential for efficient Gag polyprotein processing and viral infectivity. J. Virol. 72:3459-3463.
46. Tomasselli, A. G., M. K. Olsen, J. O. Hui, D. J. Staples, T. K. Sawyer, R. L. Heinrikson, and C. C. Tomich. 1990. Substrate analogue inhibition and active site titration of purified recombinant HIV-protease. Biochemistry 29:264-269.
47. Tozser, J., I. T. Weber, A. Gustchina, I. Blaha, T. D. Copeland, J. M. Louis, and S. Oroszlan. 1992. Kinetic and modeling studies of S3-S3′ subsites of HIV proteinases. Biochemistry 3I:4793-4800.
48. gag-polyprotein essential for H1V-1 particle formation. Virology 193:981-985.
49. Wan, M., M. Takagi, B. N. Loh, X. Z. Xu, and T. Imanaka. 1996. Autoprocessing: An essential step for the activation of HIV-1 protease. Biochem. J. 316:569-573.
50. Weber, I. T. 1990. Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases. J. Biol. Chem. 265:10492-10496.
51. Wiegers, K., G. Rutter, H. Kottler, U. Tessmer, H. Hohenberg, and H. G. Krausslich. 1998. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72:2846-2854.
52. Wlodawer, A., M. Miller, M. Jaskolski, B. K. Sathyanarayana, E. Baldwin, I. T. Weber, L. M. Selk, L. Clawson, J. Schneider, and S. B. Kent. 1989. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease. Science 245:616-621.
53. Wondrak, E. M., J. M. Louis, H. de Rocquigny, J. C. Chermann, and B. P. Roques. 1993. The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins. FEBS Lett. 333:21-24.
54. Wondrak, E. M., N. T. Nashed, M. T. Haber, D. M. Jerina, and J. M. Louis. 1996. A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation. J. Biol. Chem. 271:4477-4481.
55. Zybarth, G., and C. Carter. 1995. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. J. Virol. 69:3878-3884.